Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-23-175093
Filing Date
2023-06-26
Accepted
2023-06-26 16:13:57
Documents
1
Effectiveness Date
2023-06-26

Document Format Files

Seq Description Document Type Size
1 S-8 POS d461718ds8pos.htm S-8 POS 48437
  Complete submission text file 0001193125-23-175093.txt   49544
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-97015 | Film No.: 231042509
SIC: 2834 Pharmaceutical Preparations